Determination of binding kinetics is an imperative and laborious phase in biological drug discovery. The WAVEsystem, a Creoptix technology, was developed with researchers in mind. Based on the GCI detection principle, it provides outstanding sensitivity, reducing sample consumption and mass transfer hindrances. Combining GCI technology with our no-clog WAVEchips and waveRAPID (a new method ...
- Products:
- WAVEsystem
- Technology:
- Grating-coupled interferometry (GCI), Microfluidics
- Industry:
- Biologics, Pharmaceutical